|
Optical sensor measures blood glucose
through skin
Swiss research institute Empa and University
Hospital Zurich have developed an optical sensor that measures blood
sugar levels through the skin, without taking any blood. 23 Jan 2015
DNA Electronics acquires
nanoMR for $24m
DNA Electronics Ltd, the inventors of
semiconductor DNA sequencing technology, has completed the
acquisition of nanoMR Inc. an Albuquerque-based developer of a
system for rapid isolation of rare cells in the bloodstream, for
approximately $24 million.
ICR develops avatars to display
important cancer cell features to aid diagnosis
The Institute
of Cancer Research, London has developed new software to visualise
data generated by imaging of cancer cells in a more intuitive way
than graphs or charts. The program called PhenoPlot generates
‘avatars’ of cancer cells based on imaging data collected by robotic
microscopes. 12 Jan 2015
Massachusetts Life Sciences Center grants Cambridge Consultants $1m
to develop Ebola diagnostic kit
Massachusetts Life Sciences Center has awarded Cambridge
Consultants and non-profit enterprise Diagnostics For All $1m to
develop a low-cost point-of-care device for testing patients in
remote areas for the
Ebola virus. 5 Jan 2015
Portable blood analyser
detects Ebola virus in 75 minutes
STMicroelectronics and
Clonit, in collaboration with Italy’s National Institute for
Infectious Diseases Lazzaro Spallanzani, have developed in a few
weeks a prototype portable analyzer able to identify the presence of
the Ebola virus in less than 75 minutes. 12 Dec 2014
Prostate cancer diagnosed from
tissue sample in 90 seconds
The Fraunhofer Institute for
Ceramic Technologies and Systems (IKTS) in Dresden has developed a
device that can identify cancerous prostate tissue from a biopsy
within one and a half minutes by using laser stimulated
fluorescence. 14 Nov 2014
OJ Bio develops prototype hand-held disease diagnostics lab
Newcastle company OJ Bio has successfully completed the prototype
development of a portable wireless point-of-care diagnostic system
that accurately and quickly identifies the presence of a range of
viruses and bacteria in patient fluid samples. 7 Nov 2014
FIND and QuantuMDx partner to develop
rapid genome-based diagnostics for tuberculosis
Swiss NGO FIND
is joining forces with UK diagnostics developer QuantuMDx Group to
develop a combined solution for the rapid detection of tuberculosis
and determination of drug resistance.
New method for creating biological sensors on silicon chips
Scientists from Chile and Germany
have developed a novel process to layer two readily available
chemicals on a silicon
substrate to mimic a cell membrane and give the ability to link
biological processes to electronics. 30 Oct 2014
Welch Allyn to add Gentag's
NFC wireless technology to medical devices
Medical
diagnostics device company Welch Allyn and Gentag, a pioneer in
disposable wireless biosensors, have entered into an agreement to
bring to market near field communications technology for medical
devices and sensors 29 Oct 2014
Sound generated by knee joint
shows extent of osteoarthritis
A team led by Lancaster
University has developed a technique that uses sound waves and
computer software to assess the state of osteoarthritis in the knee.
29 Oct 2014
Lung cancer can stay dormant
for 20 years until triggered by genetic faults
Researchers at
Cancer Research UK have discovered that lung cancers can lie dormant
for over 20 years until genetic faults trigger sections to grow and
the cancer becomes aggressive. 13 Oct 2014
Genetic test identifies people
at higher risk of atrial fibrillation and stroke
People who are genetically predisposed to develop atrial
fibrillation, which increases risk of stroke, can be identified with
a blood test according to research at Lund University in Sweden. 13
October 2014
Paris Public Hospitals Group
and Magnisense partner to develop tests for cardiovascular diseases
French hospital group AP-HP, (Assistance Publique-Hôpitaux de
Paris), and diagnostics technology developer Magnisense have signed
a partnership agreement to develop rapid portable diagnostic tests
for cardiovascular diseases. 9 Oct 2014
QuantuMDx announces prototype
handheld lab for rapid DNA diagnostics
Newcastle-based
medical device developers QuantuMDx Group has announced the
successful production of their first fully-integrated
sample-to-result working prototype of Q-POC, a handheld lab that
delivers DNA-based medical diagnosis in minutes. 11 Sep 2014
New technique to test for
prostate cancer
A team of researchers at Guangdong Medical
College in China has demonstrated the potential of a new test to
detect prostate cancer combining surface-enhanced Raman scattering
(SERS) with a new technique called support vector machine (SVM). 9
Sept 2014
Roche launches automated
molecular diagnostic systems for blood and blood plasma screening
Roche has launched two integrated and fully automated molecular
testing systems for blood and plasma donor screening, the cobas 6800
and 8800, based on Nobel-prize winning PCR technology. 2 Sept 2014
Haemostasis management device
used in Afghanistan war zones approved by NICE
The ROTEM
point of care blood analyser which has been used to manage major
bleeding in soldiers in Afghanistan has now been recommended by NICE
for use by the NHS. 29 Aug 2014
Primerdesign announces lowest
cost DNA analytics device for health, veterinary, food and biothreat
testing
Southampton University spinoff Primerdesign Ltd has
announced the launch of what it claims is the world’s most
affordable device for DNA diagnostics. The genesig q16 uses
real-time PCR analysis to test DNA using a range of over 400 testing
kits
Rapid Biosensor Systems
appoints chair in move to IPO
Cambridge company Rapid
Biosensor Systems Ltd has appointed John Reynolds OBE as Executive
Chairman to take it to the next stage of growth. 12 Aug 2014
KTH designs device to sort cells by elasticity properties
Researchers at Sweden's KTH The Royal Institute of Technology
have used computational simulations to propose a microfluidic device
that can sort cells according to their elasticity. This could
offer a more reliable alternative for detecting disease biomarkers.
14 Jul 2014
Plasmonic biosensors make
highly sensitive diagnostic devices
A new type of
highly-sensitive and low-cost sensor, called a plasmonic biosensor,
could detect a range of biomarkers that diagnose diseases at an
early stage. 8 July 2014
Clearbridge BioMedics launches
device that isolates circulating tumour cells from blood
Clearbridge BioMedics has launched a new cancer diagnostic device,
the ClearCell FX System, which is able to isolate and capture
circulating tumour cells (CTCs) from a blood sample. 5 Jun 2014
QuantuMDx closes $8.42m
funding for prototyping handheld DNA diagnostics device
The
Newcastle-based diagnostics developer has announced it has closed an
$8.42m funding round syndicated with philanthropist private
investors and the University of Newcastle upon Tyne. 4 Jun 2014
MRI-guided biopsy for brain
cancer improves diagnosis
Neurosurgeons at UC San Diego Heath
System have combined real-time MRI technology with non-invasive
cellular mapping techniques to develop a new biopsy method that
increases the accuracy of brain cancer diagnosis. 6 May 2014
ValiRx cancer screening gene
biomarker granted Japanese patent
ValiRx Plc has announced
that NAV3, its cancer screening test gene biomarker has received
patent approval by the Japanese patent office (JPO). 6 May 2014
Nanosensors detect cancer from
breath
A collaboration of researchers in Switzerland and
Japan has developed portable cancer detection units using coated
nanocantilevers for diagnosis from breath. 25 Apr 2014
Codasip secures $2.8m investment for ASIP technology
Application-specific processor
developer Codasip, has announced that it has closed its first round of
public funding from Czech venture capital firm Credo Ventures. 25
Apr 2014
Blood test could predict
Alzheimer's three years in advance of symptoms showing
A team
of US researchers is patenting a blood test for Alzheimer's or mild
cognitive impairment (MCI) based on 10 lipid biomarkers associated
with the diseases. 10 March 2014
Siemens Healthcare Diagnostics
partners with Pfizer to develop diagnostic tests
Siemens
Healthcare Diagnostics and Pfizer are partnering to develop in vitro
diagnostic tests for therapeutic products across Pfizer’s pipeline.
4 Feb 2014
QuantuMDx launches
crowdfunding campaign to help eliminate malaria with handheld lab
DNA diagnostics company QuantuMDx will launch an Indiegogo
crowdfunding campaign to support malaria eradication worldwide by
further developing and trialling their handheld laboratory which can
identify malaria DNA in 15-minutes. 9 Jan 2014
University of Surrey device
identifies cancerous cells by electrical properties
A
University of Surrey research team has developed an innovative
device that can differentiate between normal and unhealthy cells by
analysing their electrical properties. 3 Jan 2013
Ultrasound microscope
identifies cancerous tissue by acoustic profile
Professor
Naohiro Hozumi of Toyohashi University of Technology has developed
an ultrasonic microscope to differentiate living tissue and cell
specimens for medical purposes. 3 Jan 2013
CEO of QuantuMDx awarded OBE
in New Year's Honours list
QuantuMDx Group’s CEO and
Co-Founder Elaine Warburton has been awarded an OBE in the New
Year’s Honours list 2014 for her services to health innovation over
the last 25 years. 3 Jan 2013
Hunt for RNA biomarkers for
prostate cancer and other diseases
The RIBOLUTION project in
Germany is developing a platform for the identification and
validation of RNA biomarkers for prostate cancer and selected
diseases based on genome-spanning screening. 19 Dec 2013
Paper-based diagnostic test
and phone app check children for vaccination
Cambridge
Consultants is working with US non-profit organisation Diagnostics
For All to demonstrate a mobile phone application that can read a
simple paper-based test for whether a child has been immunised. 11
Dec 2013
Device measures risk of
infection from a blood drop in minutes
A team at the BioMEMS
Resource Center at Massachusetts General Hospital has developed a
device to rapidly test for inflammation in response to infection. 11
Dec 2013
Trinity Biotech exhibits
cardiac diagnostics point-of-care system at MEDICA
Trinity
Biotech is displaying its new 15-minute-analysis Meritas Troponin I
(TnI) point-of-care test in Dusseldorf this week. 20 Nov 2013
Aerotel showcases smallest
hand-held ECG monitors at MEDICA
Aerotel Medical Systems is
presenting two new models of what it claims are the world’s smallest
and most accurate hand-held ECG monitors at Medica 2013. 20 Nov 2013
ARC launches non-touch medical
thermometers at MEDICA
Belfast company ARC is launching
four new highly accurate non-touch thermometers at MEDICA this week.
20 Nov 2013
Capillary Film Technology
launches microfluidic device manufacturing technology at MEDICA
Biotechnology developer Capillary Film Technology Ltd (CFT) has
announced the launch of a new fluoropolymer Micro Capillary Film
(MCF) technology. 20 Nov 2013
TB drug resistance detected in
under 15 minutes
Newcastle-based diagnostics company
QuantuMDx has been awarded a £1m grant by the UK Technology Strategy
Board to develop a new rapid test, called Q-TB, to diagnose TB and
test for drug resistance. 18 Nov 2013
Foetal heart monitor uses
magnetism to identify abnormal heart rhythms
A device that
records the natural magnetic activity of the heart of foetuses can
help identify abnormal heart rhythms in unborn babies. 14 Nov 2013
New hope for blood test to
catch pancreatic cancer early
A simple blood test to detect
gene fragments unique to pancreatic cancer cells could be on the
horizon following promising results in a small preliminary study at
Johns Hopkins Medicine in the US. 11 Nov 2013
New software detects genetic
diseases 20 times more accurately
A new set of computer
programs developed at the iMinds research institute at KU Leuven can
rapidly identify hereditary diseases from the vast amounts of data
generated by genetic analysis. 30 Oct 2013
Cepheid launches
next-generation Xpert Flu diagnostic test
Cepheid has
launched its next generation Xpert Flu test for the GeneXpert
System, offering on-demand STAT testing for triage, outbreaks,
emergencies and high risk patient management. 28 Oct 2013
IBM develops microfluidic
probe to diagnose cancer in tissue samples
IBM scientists are collaborating with pathologists at the
University Hospital Zürich to test a prototype device called a
microfluidic probe for accurately diagnosing different types of
cancer. 28 Oct 2013
Nanodiamonds monitor molecular
processes from inside cancer cells
The EU-funded project
Dinamo aims to develop a sensing platform for real-time monitoring
of biomolecular processes in living cancer cells using fluorescent
diamond particles. 28 Oct 2013
QuantuMDx wins NE innovation
award for handheld DNA sequencer
Newcastle-based diagnostics
company QuantuMDx has been awarded the Insider's 'Made in the North
East' Life Sciences trophy in recognition of its ground-breaking
handheld DNA sequencer. 10 Oct 2013
Skuldtech secures €1m to
develop blood biomarker test for Alzheimer's disease
French
biotechnology company Skuldtech has secured €1m in funding from
Bpifrance (French public financing structure) to develop a blood
biomarker test for Alzheimer's disease. 11 Sept 2013
Raman laser highlights tumour
cells in brain tissue during surgery
A new laser-based technology can identify cancerous cells
during surgery, enabling surgeons to make sure they remove all the
cells that could develop into a new tumour. 10 Sept 2013
Colour-changing dots detect blood-borne bacteria
A team at the University of Illinois has developed a cheap
disposable device containing a chemical sensing array (CSA) that can
rapidly identify bacteria from the signature chemicals that they
give off. 10 Sept 2013
Siemens launches SPECT-CT system for high resolution molecular
imaging
Siemens Healthcare's xSPECT system,
the Symbia Intevo, combines the high sensitivity of single-photon
emission computed tomography (SPECT) with the high specificity of CT
to generate high resolution and, for the first time, quantitative
images. 19 Aug 2013
Rapid tissue analysis shows
stage of bowel cancer for fine tuning treatment
Researchers
at Imperial College have measured the stage of a tumour by analysing
the chemicals produced by the tumour cells using high-resolution
magic angle spinning nuclear magnetic resonance spectroscopy. 15
Aug 2013
RNA test could detect
Alzheimer's disease
A new RNA-based blood test can
distinguish between people with Alzheimer's disease and healthy
controls. This type of test could be used to help diagnose the
disease and other degenerative disorders. 31 July 2013
New breast cancer test is better at diagnosing need for chemotherapy
A new genetic test can better determine the
likelihood of recurrence of a common form of breast cancer and help
decide on the need for chemotherapy. 2 July 2013
Blood test for pregnant women
diagnoses Down's Syndrome in foetus
A non-invasive test that
analyzes foetal DNA in a pregnant woman’s blood can accurately
detect Down’s syndrome and other genetic foetal abnormalities in the
first trimester. 7 June 2013
Microfluidic device separates non-spherical bioparticles for rapid
disease diagnosis
A team at the National University of Singapore (NUS) has
developed a novel microfluidic device that separates and detects
non-spherical bioparticles such as pathogenic bacteria and
malaria-infected red blood cells. 23 Apr 2013
Nanosensor detects cancer cells
A nanosensor that can detect cancerous skin cells by identifying
mutated RNA has been developed by the Swiss Nanoscience Institute of
the University of Basel and the Ludwig Institute for Cancer Research
in Lausanne. 27 Feb 2013
Patients at risk from
inaccurate antibiotic test kits used in hospital
pathology labs
An investigation by the British
Medical Journal (BMJ) has found that one of the world’s
leading producers of diagnostic tests has been falsely
marketing one of their products. 13 Feb 2013
Nurses at the forefront of
genomics in healthcare
A special Genomics Issue of the
Journal of Nursing Scholarship addresses genetic applications that
are essential to advancing nursing knowledge and patient care. 5 Feb
2013
Rapid identification of lung
infection by analysing volatile compounds in breath
The
chemical ‘fingerprints’ given off by specific bacteria infecting
lungs can be rapidly identified by a type of mass spectrometry. 16
Jan 2013
Q-Cancer
awarded £1.4m to develop QuantuMDx benchtop tumour profiler
The Q-CANCER project will integrate QuantuMDx Group’s rapid on-chip
lab processes and develop the first sub-20 minute tumour profiler.
23 Nov 2012
Card-sized device can
detect diseases from tiny samples in minutes
The card-sized
device, which needs no power, lays the groundwork for early-stage
point-of-care diagnosis of diseases such as cancers and Alzheimer's.
22 Nov 2012
Blackpool hospitals use genetic
testing to reduce MRSA
Blackpool Teaching Hospitals NHS
Foundation Trust has introduced rapid screening for the superbug
MRSA of all emergency admissions patients, and both MRSA and MSSA
for surgical patients admitted through A&E. 22 Nov 2012
SpinChip microfluidics
device analyses blood at the point of care
Norwegian company
SpinChip has developed a microfluidics-based chip contained in a
portable device that analyses blood samples at the point of care and
provides immediate results. 14 Nov 2012
DNA sequencing
tracks source of MRSA in hospital infection
A Cambridge-based
team has used advanced DNA sequencing technologies to confirm the
presence of an ongoing outbreak of MRSA at Addenbrooke's Hospital,
Cambridge, in real time. 14 Nov 2012
Hand-held device can diagnose flu virus
strains in minutes
Newcastle-based OJ-Bio has secured funds
to further develop a device for the rapid, simple and low cost
diagnosis of flu and other viruses. 13 Nov 2012
Zilico secures further
£750K funding for cervical cancer test
Zilico Ltd has secured
£750K investment from The North West Fund for BioMedical. This
follows £1m invesetment announced in June 2012. 6 Nov 2012
New ‘traffic light’ test could
help GPs diagnose liver disease earlier
The Southampton
Traffic Light (STL) test combines several different tests and
clinical markers that are given a score that indicates the patient’s
likelihood of developing liver fibrosis and liver cirrhosis. 5 Sept
2012
MedMira wins $4.2m US army
contract to commercialize rapid test for HIV and hepatitis
MedMira will advance and commercialize a multiple rapid test that
will simultaneously detect HIV-1/2, Hepatitis B and C antibodies
within three minutes using just a small drop of blood. 23 July
2012
New semen test for testicular
cancer
The Rigshospitalet in Copenhagen has found a new and
simple way of detecting testicular cancer before it starts, by
detecting markers in a sperm sample.
New diagnostic tool increases the value of Kancera's ROR cancer
treatment
Kancera and the Karolinska Institute have developed antibodies
that permit the development of a diagnostic tool to identify cancer
patient response to treatment using Kancera’s ROR inhibitors. 25 June
2012
Plessey launches ultra-low
cost version of EPIC sensor
Plessey Semiconductors has
released an ultra-low cost version of its award-winning EPIC sensor
that provides remote electric field sensing for high volume consumer
markets. 15 June 2012
Miniature magnetic sensor
opens new era for neurology
A new type of magnetic field
sensor, called a chip-scale atomic magnetometer (CSAM), uses
miniaturized optics for measuring absorption changes in a rubidium
gas cell caused by magnetic fields. 12 June 2012
High speed bench-top
sequencing to revolutionise hospital infection control
A new
generation of bench-top DNA sequencers can quickly and cheaply map
the entire genetic codes of bacteria causing life-threatening
infections. 11 June 2012
Electronic sensor can detect
prostate cancer cells
Scientists at the Barcelona University
have developed the main components of a biosensor containing several
hundred nanometric sized optoacoustic biosensors and that can detect
cancer cells in urine. 4 June 2012
Enzyme-coated gold
nanoparticles make ultra-sensitive disease detectors
Enzyme-coated gold nanoparticles can detect disease biomarkers at
several orders of magnitude lower concentrations than current tests
and will make it possible to detect a range of diseases earlier. 30
May 2012
Stago launches rapid HIT
exclusion test in the UK
Stago has launched a simple test
that will rapidly exclude heparin-induced thrombocytopenia (HIT),
following use of heparin in surgery, in just 10 minutes. 28 May 2012
Abbott awarded CE mark for
PLEX-ID rapid microbial identification system and clinical tests
PLEX-ID, which is based on molecular diagnostic technologies,
addresses a significant unmet need for rapid detection and
identification of a broad range of microbes that cause infections in
patients. 28 May 2012
Idaho Technology receives FDA 510(k)
clearance for rapid respiratory pathogen detection system
Idaho Technology, Inc. has announced US FDA 510(k) clearance of five
additional pathogens for its FilmArray RP system and the launch in
European markets. 28 May 2012
Michelson Diagnostics
secures £600k investment for further growth
Michelson
Diagnostics has announced a further investment of £607k by
shareholders Octopus Investments, Catapult Venture Managers and
London Business Angels. 22 Mar 2012
Revolutionary DNA
sequencing technique improves diagnosis of muscular dystrophy
Scientists at The University of Nottingham have used massively
parallel DNA sequencing to correctly identify muscle-wasting
diseases. 7 Mar 2012
Wireless self-propelled
chip swims through blood vessels
A tiny, wirelessly powered,
self-propelled medical device capable of controlled motion through
blood vessels has been developed by electrical engineers at Stanford
University. 27 Feb 2012
PneumaScan installed in
Hospital Kuala Lumpur
Cambridge company PneumaCare Limited
has installed its innovative PneumaScan respiratory assessment
device in Hospital Kuala Lumpur. 20 Feb 2012
Influenza virus diagnosed in record
time with new genetic test
The test, developed by researchers
at the RIKEN Omics Science Center can detect influenza virus
infection in 40 minutes and with one hundred times the sensitivity
of conventional methods. 2 Feb 2012
X Prize Foundation announces US$10m prize for developing
Star Trek Tricorder
The X Prize Foundation and Qualcomm Foundation
have launched the US$10 million Qualcomm Tricorder X Prize to
stimulate the development of a multipurpose consumer health
diagnostics device. 16 Jan 2012
New decision-support tool provides
earlier diagnosis in Alzheimer’s disease
The VTT Technical
Research Centre of Finland has developed a decision support tool for
objective diagnostics of Alzheimer’s disease as part of the European
PredictAD project. 13 Jan 2012
Microvisk wins Healthcare
Project of the Year after visitors queue up at Medica
Microvisk Technologies has scooped the Award at the BioNoW
Biomedical Awards. It follows the highly successful introduction of
the company's CoagMax and CoagLite devices at Medica. 9 Dec 2011
Systagenix launches point of
care test for rapid assessment of chronic wounds
Woundchek
Protease Status, the first product arising from the collaboration
with Alere Scarborough, is the world’s first rapid, point of care
test for the assessment of protease activity in chronic wounds. 28
Nov 2011
Endomagnetics raises
additional funding for novel cancer diagnostics probe
Cambridge-based Endomagnetics has raised funding totalling £1.8
million. The Company has also announced a move to Cambridge and two
new appointments as it expands its operations. 23 November 2011
Oxford Medical
Diagnostics achieves detection of 1ppm acetone in breath
Oxford University spinout Oxford Medical Diagnostics has announced
that it has achieved a significant target in developing a
cost-effective desk-top breath analysis device to diagnose diabetes.
20 Nov 2011
New method for
detecting breast cancer uses magnetic particles and SQUID
A
new and potentially more sensitive method of detecting breast cancer
has been developed that uses tumour-targeting magnetic iron oxide
particles and superconducting quantum interference device (SQUID)
sensors. 28 Oct 2011
QuantumDX licenses
nanostructures for DNA sequencing in hand-held devices
Newcastle-based QuantuMDx Group Limited has signed an exclusive
license agreement with US nanotechnology developer Nanosys Inc for
several patents and patent applications related to the use of
nanostructures for biosensors. 23 October 2011
Cerebrospinal fluid is key to early
diagnosis of different types of dementia
Different forms of
dementia leave different biochemical fingerprints in the
cerebrospinal fluid before any clinical symptoms emerge, researchers
at the Sahlgrenska Academy in Sweden have discovered. 11 Oct 2011
Max Medical to
show new range of diagnostic and monitoring devices at Medica 2011
Max Medical are displaying a range of new products at Medica in
Dusseldorf in November, including first aid kits, blood glucose
monitoring devices, and blood pressure monitors. 29 Sept 2011
New aptamer based sensors will lead
to cheap ultra-portable blood testing
The University of
Toledo in Ohio has developed a low-cost, portable technique that is
able to quickly and reliably detect specific proteins in a sample of
human blood. 20 September 2011
UCLA creates cheap
light-weight lens-free microscope using holograms
The
prototype weighs about as much as a medium-sized banana and fits in
the palm of a hand. It could be used to improve healthcare in remote
areas of the world with little access to expensive diagnostic
equipment. 20 Sept 2011
Microvisk introduces world’s
first MEMS-based diagnostics system in the US
North
Wales-based Microvisk Technologies has introduced its handheld
devices that monitor the blood clotting status of patients to the US
market. 31 August 2011
Dogs can detect lung cancer from
breath
Sniffer dogs could be used for the early detection of
lung cancer from the breath of patients, according to researchers at
Schillerhoehe Hospital in Germany. 25 August 2011
Simple blood oxygen test
identifies newborns with dangerous heart defects
A simple
test to measure blood oxygen in newborns has been shown to identify
babies with life-threatening congenital heart defects, a major cause
of infant mortality in the developed world. 13 August 2011
Innovative diagnostic devices win NHS Smart Solutions competition
A cardiovascular screening system that uses retinal images, new
devices to detect blocked leg arteries and neuropathy in diabetics,
and a service which uses a monitoring device to diagnose sleep
apnoea in patients’ own homes, are the winners of an NHS
competition. 11 August 2011
Plessey Semiconductors wins award
for novel electric field sensor technology
The EPIC sensor is
a completely new area of sensor technology that measures changes in
an electric field in a similar way to a magnetometer detecting
changes in a magnetic field. 9 June 2011
New marker for prostate cancer
gives hope for more accurate diagnosis than PSA test
Researchers at Uppsala University have discovered a promising new
marker for diagnosing prostate cancer. Their unique method could
lead to more reliable diagnoses and fewer unnecessary operations. 18
May 2011
Xpert test for TB proven fast
and effective in developing country settings
The
effectiveness of the Cepheid Xpert MTB/RIF test for tuberculosis and
rifampicin resistance in realistic healthcare field conditions has
been reported in a study in The Lancet. 4 May 2011
New weapons needed to tackle
growing threat of tuberculosis
Leading experts from 12
countries discussed the growing threat from tuberculosis at a
conference at the Institute of Tropical Medicine (ITM) in Antwerp
this month. 28 March 2011
New EU-funded projects to find
new cures for tuberculosis
To mark World Tuberculosis Day the
European Commission has announced that it is supporting new projects
aimed at finding new cures for the disease. 28 March 2011
Bruker launches portable toxin
identification system
The benchtop, push-button pTD system is
intended for smaller, field and mobile laboratories for use by
non-expert operators in homeland security applications. 17 Feb 2011
Caliper and Seegene partner to
provide multiplex molecular diagnostics products
Caliper Life
Sciences, Inc. and Seegene, Inc. have entered into a strategic
partnership to enable Seegene's SeePlex multiplex diagnostic assays
to run on Caliper's innovative LabChip Dx platform. 31 Jan 2011
Caliper launches LabChip Dx
for molecular diagnostics
The LabChip Dx system uses the
company's proprietary microfluidic technology and is aimed at
clinical research laboratories developing molecular diagnostic
tests. 31 Jan 2011
Sepmag awarded Chinese patent
for homogenous biomagnetic separation
The company's novel
technique applies less pressure on particles and guarantees users
consistently reproducible results in their in vitro
diagnostics kits. 24 Jan 2011
Mobile platform for fast
sepsis diagnosis
A new credit-card-sized diagnostic platform
being developed at the Fraunhofer Institute for Cell Therapy and
Immunology will be able to diagnose sepsis in as little as an hour.
6 Jan 2011
Portable device for breast
cancer screening moves closer to market
A new portable device
that detects breast cancer based on tissue elasticity has come a
step closer to market with its licensing by a medical device
company. 10 Dec 2010
DARPA awards Georgia Tech
$4.3m to develop biochemical sensors
The US Defense Advanced
Research Projects Agency (DARPA) has awarded the Georgia Institute
of Technology $4.3m to develop a new class of sensors able to detect
multiple biological and chemical threats simultaneously. 10 Dec 2010
Abbott joins Clinton Health
Initiative to improve HIV testing in Africa
Abbott will
supply its RealTime HIV-1 qualitative test kits to healthcare
facilities and also offer the capability to collect and process
samples using dried blood spots. 23 Nov 2010
High quality diagnostic testing and manufacturing showcased at
MEDICA
Contract manufacture services for lateral flow assays will be
showcased at MEDICA this month by York-based company Forsite
Diagnostics. 11 Nov 2010
Barcode system to correctly
identify patient samples
The Brenmoor PATscan system
duplicates patient’s information from a printed wristband straight
onto a label in less than a second, enabling correct identification
of hospital samples. 25 Oct 2010
Welch Allyn launches handheld
digital blood pressure device to world markets
Welch Allyn
has introduced the Connex ProBP 3400, an automated digital blood
pressure device designed to fit in the palm of the hand.
It
provides a portable option for capturing reliable blood pressure
readings in virtually any hospital or primary care environment. 21
Oct 2010 Deutsch
Français
Español
St George's Hospital selects
MDI's PCR-based assay for MRSA screening
Molecular Detection
Inc's Detect-Ready MRSA assay has received its first independent
validation in a study conducted at St George's Healthcare NHS Trust,
London, which is now using it for screening. 21 Oct 2010
UK government announces £50m
funding for personalised medicine
The Stratified Medicines
Innovation Platform is a new government initiative providing over
£50 million of funding for research and development in diagnostics
and pharmaceuticals for personalised medicine. 15 Oct 2010
GATC Biotech first in Europe
to use PacBio RS gene sequencer
German gene sequencing
service provider GATC Biotech has announced that it has agreed to
purchase the PacBio RS platform, a single molecule, real-time (SMRT)
gene sequencing technology. 11 Oct 2010
Friarage Hospital improves
workflow for chemistry and immunoassay testing
Friarage
Hospital in Yorkshire has installed the UK’s first VersaCell sample
management system combining chemistry and immunoassay analysers from
Siemens Healthcare Diagnostics. 11 Oct 2010
LabCorp in $925m takeover of
Genzyme Genetics
Laboratory Corporation of America Holdings
has agreed to acquire Genzyme Genetics, a business unit of Genzyme
Corp and a leading provider of complex reproductive and oncology
testing services. 15 Sept 2010
 MIRACLE project launched to develop
lab-on-chip for cancer diagnosis
The EU funded MIRACLE
project, launched on 1 September, aims to develop an operational
lab-on-chip for the isolation and detection of circulating and
disseminated tumour cells in blood. 3 Sept 2010
Siemens introduces new systems for the
diagnosis and therapy of heart diseases
Siemens Healthcare
is presenting at the European Society of Cardiology Congress 2010 a
range of innovative solutions for cardiology that provide higher
quality of care and contribute at the same time to reducing costs in
healthcare. 1 Sept 2010
Spartan Bioscience announces first
point-of-care DNA testing system for personalized medicine
The Spartan RX, a complete sample-to-result, point-of-care DNA
testing system for personalized medicine. The non-invasive system
provides automated results in one hour. 18 August 2010
MabCure's blood test for ovarian
cancer gets positive results
Cancer diagnostics developer
MabCure, Inc. has announced that a confirmatory study demonstrated the
company’s proprietary monoclonal antibodies (MAbs) successfully
identified ovarian cancer in blood (94% accuracy) and with no false
positives or cross-reactions with benign ovarian tumours or healthy
blood. 12 August 2010
Aloka e-flow technology improves
accuracy of coronary heart diseases diagnosis
The Universidad
Complutense de Madrid is using Aloka’s e-tracking technology to advance
the early detection of cardiovascular events.
The system is used to
easily measure predominant parameters on arterial vessels. 2 August 2010
BAE Systems wins $17m US army
contract for head-worn brain injury sensor
BAE Systems has
received an initial order of $17 million from the US Army for its
Headborne Energy Analysis and Diagnostic Systems (HEADS) to help address
combat-related traumatic brain injuries (TBI) in Iran and Iraq. 14 July
2010
FDA approves test for early
diagnosis of AIDS from HIV antigen
The US FDA has approved an
innovative new diagnostic tool from Abbott that can detect the AIDS
antigen and give a diagnosis of AIDS earlier than ever before. 14 July
2010
Computerised blood pressure
diagnosis beats hypertension experts
Irish Company dabl’s
computerised system for diagnosing 24-hour blood pressure is more
accurate and consistent than a leading group of international
hypertension experts, according to an independent study. 30 June 2010
Ingen launches in vitro diagnostic
kit for joint replacement infections
Ingen Biosciences has
launched in Europe the first in vitro diagnostic kit to detect
infections in prosthetic replacements. The diagnostic kit, BJI InoPlex,
is built around Ingen Biosciences’ proprietary antigen technology. 30
June 2010
Simple urine test could diagnose
autism
Children with autism have a different chemical fingerprint
in their urine than non-autistic children. The finding could ultimately
lead to a simple urine test to determine whether a child has autism. 18
June 2010
Ambry Genetics introduces test to
identify carriers of newborn genetic disorders
Ambry Genetics has
launched AmbryScreen, a genetic screening test used to identify carriers
of some of the most severe and common childhood diseases affecting
pan-ethnic populations. 14 June 2010
Blood test for detecting cancers five years before visible in diagnostic imaging
A ground-breaking diagnostic
test that can identify biomarkers in blood for a range of cancers as
much as five years earlier than current diagnostic imaging methods will
be launched this month. 2 June 2010
Nanoscale glass conductors for new
class of lab-on-chip devices
The discovery of a new electrical
phenomenon that only acts at the nanoscale could lead to faster, less
expensive lab-on-a-chip diagnostic devices. 24 May 2010
Novel rapid point-of-care test
kits bring low cost diagnostics for HIV and AIDS
Low-cost test
kits that measure CD4 T-cells in blood samples, markers of the immune
system, will give HIV/AIDS patients access to antiretroviral drugs
faster. 10 May 2010
Nanosensors powered by
piezoelectric nanogenerators
By combining a new generation of
piezoelectric nanogenerators with two types of nanowire sensors,
researchers at the Georgia Institute of Technology have created what are
believed to be the first self-powered nanometer-scale sensing devices
that draw power from the conversion of mechanical energy. 21 April 2010
Siemens expands Clinitek point of
care urinalysis porfolio
Siemens Healthcare Diagnostics has
launched the Clinitek Status+ Analyser and the Clinitek Status Connect
System for urinalysis and pregnancy testing at the point of care. 2
April 2010
Promega Maxwell 16 in vitro
diagnostics system gains EU approval
The Promega Maxwell 16 IVD
System has gained the CE marked for in vitro diagnostic medical devices.
The CE mark applies to the instrument, the Maxwell 16 Blood DNA
Purification System and the Maxwell 16 Viral Total Nucleic Acid
Purification System. 2 April 2010
Alliance Biosciences provides HIV
and TB biosafety guidance to Kenyan orphanage
Alliance
Biosciences has reached an agreement with the Nyumbani Children's Home
in Kenya to provide engineering and biosafety guidance to Nyumbani's
planned HIV/TB diagnostic facility. 9 March 2010
Diagnostic Hybrids receives FDA
emergency use authorization for H1N1 influenza A virus ID kit
The
kit is a monoclonal antibody fluorescent staining kit for the specific
identification of 2009 H1N1 influenza A in direct patient specimens or
incubated tissue cultures. 9 Mar 2010
Sebia launches Capillarys 2 Flex
Piercing for diagnostics labs
Sebia has unveiled the latest
addition to its automated capillary electrophoresis portfolio, the
innovative Capillarys 2 Flex Piercing for clinical diagnostic
laboratories. 5 Mar 2010
PositiveID acquires non-invasive
glucose detection technology with takeover of Easy Check
PositiveID Corporation has acquired intellectual property rights and
assets of Easy Check Medical Diagnostics, LLC, to expand its portfolio
of non-invasive glucose-level testing products and diabetes management
tools under development. 23 Feb 2010
Chip for measuring male fertility is
first stage in home testing kit
A new ‘fertility chip’,
developed by researchers at the University of Twente’s is an
important step towards the development of a compact device for
reliable ‘pre-scanning’ of male fertility. 23 Feb 2010
Robotic patient helps Bath pharmacy
students practice diagnosis
A robot that can be programmed to
have a range of medical conditions, from heart disease to
constipation, is being used by pharmacy students at the University
of Bath to help practise diagnostic skills and treating patients. 23
Feb 2010
Femtomedicine — the new frontier
of biomedical sciences
Femto-neutrons or ‘femtons’ are fast
neutrons of femtometer wavelength — a million times smaller than nano
scale — that can be used for a completely new rapid method of cancer
diagnostics. 15 Feb 2010
Antibody-coated nanoparticles in
microfluidic chip improve cancer detection 100 fold
The Fraunhofer Institute for Silicate Research is developing a highly
sensitive method for detecting cancer that can detect single molecules
of compounds in the blood that accompany specific types of tumour. 5 Feb
2010
Converging nanotechnology with the
life science industry: Nano4Life 2010
Organised by NanoKTN in collaboration with The Wellcome Trust, the
conference will be held in London on 4 Feb. 1 February 2010
 GE
develops wearable RFID sensor to detect airborne chemical agents
GE Global Research has been awarded US$2 million to develop wearable
RFID sensors to alert people to the presence of environmental chemical
agents in the air and signs of disease present in exhaled breath. 9 Dec
2009
Welch Allyn converges diagnostics
with electronic connectivity
Welch Allyn showcased its newest suite of core diagnostics product
offerings with next-generation electronic connectivity at Medica 2009 in
Dusseldorf last week. 4 Dec 2009
IBM creates rapid diagnostic
testing system on a chip
Researchers at IBM's Zurich labs have created a point-of-care
diagnostic test system based on microfluidics on a
silicon chip. The lab-on-a-chip requires less sample volume, is
significantly faster, portable, easy to use and can test for many
diseases. 18 Nov 2009 Deutsch
Diagnostic Hybrids
gains FDA clearance for influenza A and B virus identification kit
Diagnostic Hybrids has announced FDA (510k) clearance of its D3
FastPoint L-DFATM Influenza A/ Influenza B Virus Identification Kit. 13
Nov 2009
Manhattan Scientifics and Senior
Scientifics collaborate to develop cancer cell detection system
Manhattan Scientifics and Senior Scientific, LLC are co-operating to
commercialize Senior Scientific’s magnetic needle leukemia cancer cell
detection invention based on the use of nanoparticles. 12 Nov 2009
Zilico to exhibit pioneering device
for rapid detection of cervical cancer at Medica
A pioneering device that offers a quicker, more accurate detection of
cervical cancer in real time, removing several weeks of waiting for a
diagnosis, is being exhibited by British company Zilico Ltd for the
first time at Medica 2009. 3 Nov 2009
High precision analyser for medical
and military applications
Revolutionary technology for analysis of chemical and biological
substances developed at the University of Delaware holds promise in
multiple applications, ranging from the early detection of diseases, to
monitoring for chemical weapons and environmental pollutants. 3 November
2009
FDA publishes guidance on developing diagnostic tests for 2009 H1N1
flu virus
During a pandemic manufacturers can submit a request to the FDA for an
Emergency Use Authorization to allow unapproved tests that meet certain
criteria to be used for diagnosis. 3 Nov 2009
eBioscience acquires Bender
MedSystems' immunoassay technology
eBioscience Corporation has acquired privately held Austrian immunoassay
technology pioneer Bender MedSystems GmbH in an all cash transaction. 27
Oct 2009
High tech gas sensors for premium
cars turned into diagnostic device for human diseases
High-tech gas sensors normally used to test components for premium cars
have been used by researchers at Warwick University to analyse human
blood and urine, and even cow dung samples to test their feasibility for
diagnosing diseases. 28 Oct 2009
Cepheid wins grant to develop
ten-colour real-time PCR detection technology
Cepheid has received a notice of grant award from the US National
Institute of Allergy and Infectious Diseases to develop new ten-colour
detection technology for use in its GeneXpert System. 27 October 2009
Siemens wins $135 million service contract
from US health system
The University of Pennsylvania Health System has awarded Siemens
Healthcare a $135 million
contract for integrated service management for diagnostic systems and bio-medical
devices. 21 Oct 2009 Deutsch
Breakthrough in lab-on-chip for
fast breast cancer detection
The EU-funded MASCOT project has developed a set of modular components
for construction of a lab-on-chip system for detection of tumour cells
in blood samples. The modules are now ready for integration into a
single lab-on-chip and clinical evaluation. 14 Oct 2009
Claros Diagnostics receives ISO
13485 certification for point-of-care blood-test system
Claros Diagnostics, a developer of novel point-of-care immunoassay
systems, has reported the receipt of corporate ISO 13485 and CMDCAS
certificates of registration issued by the National Standards Authority
of Ireland (NSAI). 14 October 2009
Blood flow blockages in heart measured using wireless fractional flow
reserve technology
St Jude Medical, Inc. has announced the first use of the PressureWire Aeris technology, an interventional tool which measures
Fractional Flow Reserve (FFR) to evaluate the severity of blood flow
blockages in the arteries. 13 Oct 2009
Philips develops
breakthrough photomultiplier for medical imaging and diagnostics
Royal Philips Electronics (NYSE: PHG, AEX: PHI) has announced
that its scientists have developed a highly innovative digital
silicon photomultiplier technology that will allow faster and
more accurate photon (the basic quantum unit of light) counting
in a wide range of applications where ultra-low light levels
need to be measured.8 October 2009
Promising results for rapid
viral diagnosis tests in emergency rooms
Rapid viral diagnosis tests for respiratory diseases in children
who arrive in emergency departments have the potential to reduce
pressures on health systems by enabling doctors to reach a
quicker diagnosis, according to Cochrane Researchers. 5 Oct 2009
New test identifies active TB in smear-negative patients
Researchers in the Tuberculosis Network European Trialsgroup
have found that the enzyme-linked immunospot
assay (ELISpot) can detect active tuberculosis in patients with negative
sputum tests and give test results in one day. 5 Oct 2009
Breast cancer detector with
a unique touch
Researchers at Drexel University in the US are developing a new
portable, low-cost, breast cancer detector based on
piezoelectric fingers that measure stiffness and mobility of
breast tissue. 5 Oct 2009
UTAS chooses ADI Blackfin
processors for patient monitoring and diagnostics devices
Patient monitoring and diagnostics device manufacturer
UTAS has selected Analog Devices' Blackfin processors to ensure
high-performance digital signal processing operations and robust
functionality across its full line of products. 2 Oct 2009
Cepheid accelerates
development of rapid flu A panel test
Cepheid has announced the accelerated development of a Flu A
Panel test for use on the GeneXpert System. The test will be
designed to provide 45-minute identification of flu A infection,
with specific presumptive identification of seasonal H1,
seasonal H3, and H1N1 novel strain types. 22 Sept 2009
PrimerDesign develops
world's first test kit for Tamiflu-resistant swine flu
Gene detection specialists PrimerDesign have developed a swine
flu test kit that identifies the Tamiflu-resistant strain within
2 hours compared to the usual three days. 11 Sept 2009
PerkinElmer launches
multiple steroid diagnostic kit for hormone and endocrine
disorders
The Child Health System steroid profiling kit and data suite
software can simultaneously measure ten different steroids in
biological samples for diagnosing hormone imbalances or
endocrine diseases in both children and adults. 10 September
2009
Diagnostic Hybrids releases
Thyretain for specific detection of thyroid stimulating
immunoglobulin
Thyretain is the first FDA-cleared test that specifically
detects TSI and is to be used as an aid in the differential
diagnosis of Graves’ disease, an autoimmune thyroid disorder.1
September 2009
Philips launches new
cardiograph with rapid diagnosis
The PageWriter TC50 cardiograph offers an intuitive operation
and advanced clinical decision support. 28 August 2009
Simple blood test may help
predict risk of Alzheimer's
Scientists at UCLA have discovered a way to measure the amount
of amyloid beta that is being absorbed by immune cells in the
blood. If the immune system isn't adequately clearing amyloid
beta, it may indicate Alzheimer's risk. A diagnostic blood test
is now being developed for public use. 9 August 2009
Lab-on-a-chip analyses
blood with optical detector
The EU-funded NEMOSLAB project is developing an integrated ‘lab
on a chip’ that can simultaneously test a blood sample for
several different molecules at the point of care. 24 July 2009
Luminex launches two new
cystic fibrosis tests in Europe
The new xTAG tests will be used to provide assistance in cystic
fibrosis screening for newborns and confirmatory diagnostic
testing in newborns and children. The tests also can be used for
carrier testing in adults of reproductive age. 17 July 2009
Availability of diagnostic
tests drive success in hospital short-stay units
The most important factors for a successful stay in hospital
short-stay units (SSUs) are the types of diagnostic tests
performed and whether or not specialty consultations are needed.
29 June 2009
BRNI and Inverness Medical
Innovations to develop commercial skin test to detect early
Alzheimer's disease
The Blanchette Rockefeller Neurosciences Institute (BRNI) and
Inverness Medical Innovations, Inc. (Inverness, NYSE:IMA) have
announced that they will work together to further develop and
commercialize a diagnostic test for Alzheimer's disease first
discovered by scientists at BRNI. 18 June 2009
Vivacta raises US$4.5 million
to commercialise piezofilm technology for point-of-care
diagnostic tests
Kent-based diagnostic technology company Vivacta has announced
that following successful development of its thyroid function
test, it has closed a financing round that was fully subscribed
by existing investors. 18 June 2009
Siemens develops RAPID2 system
for fast discovery of pathogen signatures
Siemens Corporate Research has developed the RAPID2 system to
speed the biomarker discovery process for the development of
rapid diagnostic tests. This system marries the power of
information technology with genomic sequencing to quickly
identify genomic signatures unique to tested organisms. 16 June
2009
New peptide indicates
Alzheimer's disease before brain is damaged
Researchers at Osaka University in Japan have discovered a
peptide in cerebrospinal fluid (CSF) that can show whether a
person is developing Alzheimer's disease. Measuring the level of
this peptide could show that the disease process has started,
long before any serious damage is done to the brain and allow
early treatment. 10 June 2009
Report: Top Ten Global In-Vitro Diagnostics Companies
The global in-vitro diagnostics (IVD) market is forecast to grow at a
rate of 6% to reach $50.0bn in 2012. Roche is the largest player in the
market with a share of 20%. It is followed by Siemens and Abbott, who
both hold 12% of the market. The IVD market is highly consolidated, with
the top ten players holding close to 80% market share. A number of large
in-vivo players have entered the IVD market recently, signalling the
convergence of the two diagnostic fields. Siemens Healthcare is a
prominent example of this trend, following their acquisition of DPC,
Bayer Diagnostics and Dade Behring.
more ...
UK company produces first DNA
test kit for Mexican swine flu
PrimerDesign Ltd based in Southampton says it has won the race
to produce the first DNA test kit for the Mexican swine flu A
(H1N1). The rapid test gives results in only two hours compared
to two days for current diagnostic tests. 11 May 2009
Proof-of-concept for breast
cancer diagnostics shown for ExonHit's RNA splicing platform
Paris-based ExonHit Therapeutics has reported the publication in
Lancet Oncology of a study conducted by Institut
Gustave Roussy, which describes the identification of a
deregulated cell function in breast cancer through the analysis
of alternative RNA splicing. 23 March 2009
Lab21 acquires Biotec
Laboratories
Lab21 Ltd of Cambridge, UK, has announced that it has purchased
the majority shareholding of another UK company Biotec
Laboratories Ltd, a clinical diagnostic company with particular
emphasis on infectious diseases. 10 March 2009
Study on role of hormone
oxytocin in causing autism
A research team at the Stanford University School of Medicine
and Lucile Packard Children’s Hospital in the US will test
whether impaired social behaviours in autism are linked to
levels of the hormone. Preliminary research has hinted that
autism may be associated with oxytocin deficits 2 March 2009
deCODE genetics offers
cut-price genetic test for heart risks during February
deCODE genetics is offering its deCODEme Cardio Scan, a unique
new tool that enables individuals to better understand their
inherited risk of heart problems such as heart attack, stroke,
abdominal aortic aneurysm, for $100. 12 February 2009
Non-invasive therapies and
diagnostics on the increase
Non-invasive methods are on the increase for medical treatment,
patient monitoring and diagnostics as they can help to avoid
infections and mean less pain and stress for patients. 11
February 2009
Sysmex in agreement to
distribute AdnaGen cancer diagnostic tests in Europe
Sysmex Europe GmbH and AdnaGen AG have entered into a
non-exclusive European distribution agreement for AdnaGen
proprietary CE-certified diagnostics as well as their research
use only (RUO) products. 10 February 2009
Navigenics launches portal to
give doctors access to patients' genomic information
For patients choosing to receive a Navigenics service through
their physician, this portal allows the physician to integrate
patients’ genetic information into personalized health plans
designed to help diagnose early or prevent a number of health
conditions. 10 February 2009
Novel cheap blood test for
hepatitis C
A multinational team of researchers has developed a novel blood
test that could bring a breakthrough in the battle against the
dangerous hepatitis-C virus. This procedure offers a
considerably cheaper alternative to the normal commercial tests,
whilst maintaining equal sensitivity. 10 February 2009
EXACT Sciences in strategic
relationship with Genzyme for DNA diagnostics technology
Genzyme has acquired intellectual property assets related to
prenatal and reproductive health and three million shares of
EXACT common stock for $24.5 million. 9 February 2009
New website shows benefits of piezofilm technology
in diagnostics
The benefits of using piezofilm detection technology at the Point of
Care are described on a new website launched by Vivacta, a developer of
the technology. 31 January 2009
 Malaria
diagnostic test on a card gives hope for developing countries
Researchers at the University of Washington have developed a
prototype malaria test printed on a disposable Mylar card the
size of a credit card. The key to the test is not only
miniaturised lab-on-a-chip technology, but also the use of sugar
to keep the dried reagent viable for months without
refrigeration. 26 January 2009
Tyrian Diagnostics and
Becton, Dickinson and Company complete feasibility study for
tuberculosis diagnostic
Tyrian Diagnostics Limited has completed Milestone 4 of a
feasibility study in collaboration with Becton, Dickinson and
Company (BD) to determine the suitability of Tyrian’s
proprietary tuberculosis (TB) protein markers for the
development of rapid diagnostic tests to detect active TB
disease. 22 January 2009
MicroPhage successfully
completes beta trial for rapid MRSA test
MicroPhage has announced that its new bacterial identification
test that rapidly identifies MRSA infections has concluded its
first multicenter clinical trial. The company also reported the
trial results have surpassed its early-stage performance
expectations. 21 January 2009
Cheap reliable diagnosis
for tuberculosis urgently needed
TB kills 2 million a year in developing countries and the threat
of TB outbreaks even in Europe and North America costs these
countries hundreds of millions of Euros to control every year.
Yet the immediate, solvable challenge in TB is simply to
diagnose the disease quickly and simply with robust,
fully-tested kits. 8 January 2008
German innovation for
HIV/AIDS diagnostics used 2.5 million times in 2008
During 2008, 2.5 million patient tests have been performed with
Partec's CyFlow system, which is already supporting more than 1
million people living with HIV/AIDS. 17 December 2008
EU project developing DNA
diagnostic device for doctor's desktop
The SMART-BIOMEMS project is developing a lab on a microfluidic
chip that can be used in a portable diagnostic device to
simultaneously and automatically analyse various DNA samples
with high precision. 10 December 2008
Hospital on a chip could increase survival of battlefield wounded
Researchers in the US aim to develop an implantable biochip that
could diagnose and provide medication to soldiers as soon as they are
injured. Survival of battlefield wounds often depends on the level of
treatment within the first 30 minutes, so providing instant treatment to
wounded soldiers before a medic can reach them could increase chances of
survival. 8 December 2008
Draeger DrugTest 5000
rapidly detects addictive drugs from saliva
The Dräger DrugTest 5000 can detect up to six different drug
classes from samples of saliva within minutes. The system is
compact, simple and hygienic to use. It also has data management
capabilities to ensure sample documentation is easy to create.
26 November 20008
Philips announces breakthrough
in point-of-care testing using nanotechnology
Philips’ new Magnotech technology uses magnetic nanoparticles to
measure target molecules. The ease of use and accuracy of this
new technology could speed up the diagnosis of life-threatening
diseases and bring complex in-vitro diagnostic tests out of the
laboratory to the patient’s bedside and at home. 25 November
2008
Nanogen partners with Menarini
to market molecular diagnostic kits in Europe
Under the agreement, Menarini will commercialize CE marked IVD
infectious disease kits based on Nanogen’s proprietary MGB
technology. 12 November 2008
Radiometer adds NT-proBNP and
Troponin T to its cardiovascular point-of-care portfolio
Radiometer has added assays for NT-proBNP and Troponin T to the
panel of cardiovascular markers that can be assessed at the
point of care using its new AQT90 FLEX POC immunoassay platform.
9 November 2008
Landmark 20-year study to
assess impact of personal genetic testing
A US consortium is undertaking a first-of-its-kind study to
assess the behavioural impact of personal genetic testing on up
to 10,000 people to see how it affects their health and to
identify their potential risk for developing certain diseases.
14 October 2008
bioMérieux to develop
non-invasive test for prostate cancer
French in vitro diagnostics company bioMérieux has signed a
license and development agreement with German biotechnology
company ProteoSys for its novel prostate cancer marker Annexin
3, which will be used to develop a urine-based, confirmatory
diagnostic test for prostate cancer. 2 October 2008
Francais
Enigma Diagnostics awarded
£1.8 million to develop rapid DNA test for infectious diseases
Enigma Diagnostics will develop a 'gold-standard' portable,
rapid, automated DNA analysis (PRADA) molecular test system for
the diagnosis of infectious diseases in decentralised and
point-of-care settings such as GP surgeries. 23 September
Agendia and Ferrer in sales
agreement for cancer diagnostic services in European markets
Agendia BV and Ferrer inCode have announced an agreement that
will give Ferrer exclusive rights to sell two of Agendia's
signature cancer diagnostic services in Germany, France, Italy,
and Portugal. 17 september 2008
Genetic testing can help
predict treatment response in colorectal cancer
Genetic testing can identify a group of patients with advanced
colorectal cancer who are likely to survive on average twice as
long if treated with the drug cetuximab, new results have shown.
17 September 2008
Fairway Medical Technologies
wins US Navy contract to develop battlefield blood-borne
pathogen detector
Fairway Medical Technologies has received a $900,000 contract
from the US Department of the Navy to apply its pulsed laser
optoacoustic technology to the real-time detection of blood
borne pathogens and biological warfare agents under battlefield
conditions. 12 September 2008
Report: Molecular Diagnostics. Technologies, Markets and
Companies
This best-selling report describes and evaluates the
molecular diagnostics technologies that will play an important
role in practice of medicine, public health, pharmaceutical
industry, forensics and biological warfare in the 21st century.
Aimed at chief executives and chief development officers, it is
the most comprehensive and up-to-date one-stop source of
information on technical and commercial aspects of molecular
diagnostics. It includes profiles of 250 companies. 9 September
2008
more ...
Report: Point of Care Diagnostic Testing. World Markets
The report describes the specific market segment of the in vitro
diagnostics market called point-of-care testing (POCT). It
examines these clinical measurement devices and their reagents
and supplies as utilized in near-patient environments like
hospitals, clinics and doctor's offices. The study defines the
dollar volume of sales, both worldwide and in the US, and
analyzes the factors that influence the size and the growth of
the market segments.
more ...
9 September 2008
Protein microchip breakthrough
could lead to rapid detection of diseases and drug discovery
A new method for attaching active proteins to biological
microchips that could lead to rapid detection of disease and
identification of new drugs has been developed by Scientists at
the University of Manchester. 8 September 2008
Tepnel and SoftGenetics to
offer rapid analytics for congenital disorders
Tepnel Life Sciences plc and SoftGenetics will market and
distribute SoftGenetics GeneMarker genotyping software for use
with Tepnel’s Elucigene QST*R products for prenatal detection of
common chromosome abnormalities such as Down syndrome. 27 August
2008
DNA technology shows
high sensitivity for colorectal cancer from stool sample
EXACT Sciences Corporation (NASDAQ: EXAS) has announced the
results of a study that showed that improved 'BEAMing DNA'
detection technology demonstrated 92% sensitivity for detecting
colotectal cancer from stool samples. 27 August 2008
University of Twente awarded €2.4m
grant for research into point-of-care diagnostics
The University of Twente in the Netherlands has been awarded a grant
of €2.4 million euros from the
European Research Council for its eLab4Life project that will research
lab-on-a-chip systems for point-of-care diagnostics. 21 August 2008
Lab21 to market deCODE genetic
tests for common diseases in UK
Cambridge company Lab21 Limited has entered into a partnership
with Icelandic company deCODE genetics, to offer deCODE’s tests
for predisposition to a growing number of common diseases. 13
August 2008
Heritage Labs launches home
diabetes test kit
US laboratory services company Heritage Labs has introduced a
home testing kit for diabetics. The Appraise Home A1c Kit is a
new at-home consumer product that measures the average blood
glucose level of diabetics and potential diabetics. 13 August
2008
CHAD Therapeutics receives FDA
clearance for sleep diagnostic device
Dormio Tech, a division of CHAD Therapeutics, Inc. has received
510(K) clearance from the FDA to market its FloChannel
Diagnostic System in the USA. It is Dormio's first product for
the sleep disorder market. 6 August 2008
Discovery of cardiovascular
disease antibodies may lead to immunization
Low levels of naturally occurring antibodies may represent an
increased risk of developing cardiovascular disease,
particularly stroke in men. This discovery, published in the
journal Atherosclerosis, has now led to attempts to develop an
immunization against cardiovascular disease. 6 August 2008
Precise low-dose drug
monitoring essential for long-term kidney transplant success
The ability of blood tests to precisely measure very low doses
of anti-rejection drugs in kidney transplant patients may make a
significant difference in assuring long-term viability and
survival, according to research presented at the American
Association for Clinical Chemistry (AACC) annual meeting last
week. 6 August 2008
Kit for rapid assembly of lab-on-a-chip
University of Michigan engineers engineers have developed a kit for
researchers to make custom microfluidic devices. The 16-piece
lab-on-a-chip kit will bring microfluidic devices to researchers that
don't have the funds, technology or skills to design and manufacture
them from scratch. 5 August 2008
Abbott invests further US$20M
in Ibis Biosciences' biosensor platform
The investment will allow Ibis to further develop the Ibis T5000
Biosensor System, which offers a unique solution for rapid
identification and characterization of infectious agents, such
as bacteria, viruses and fungi. 30 July 2008
Osmetech receives FDA
clearance for warfarin sensitivity test
Molecular diagnostics company Osmetech plc has received 510(k)
clearance from the US Food & Drug Administration for its eSensor
Warfarin sensitivity test to be used as an aid in the
identification of patients at risk for increased sensitivity to
the widely used blood-thinning drug, warfarin. 30 July 2008
BD gains EU approval for
Clostridium difficile diagnostic test
BD Diagnostics has gained EU approval for its GeneOhm Cdiff
molecular assay for the rapid diagnosis of patients with
Clostridium difficile infection (CDI). The test combines
high assay sensitivity with a rapid turnaround time of less than
two hours. 16 July 2008
Vivacta gears up for pilot
manufacture of piezofilm assays
Vivacta is gearing up for pilot manufacture of its highly
sensitive, disposable piezofilm sensors for point of care (PoC)
diagnostics by acquiring an extra 6,000 sq ft of space within
its facility at Kent Science Park. 10 July 2008
New type of ultraviolet diode
could lead to compact anthrax detector
A new class of ultraviolet photodiode could make possible a
compact, reliable and cost-effective sensor to detect anthrax
and other bioterrorism agents in the air. 29 June 2008
Johnson & Johnson acquires
Swedish in vitro diagnostic technology company Amic
Johnson & Johnson Nordic AB, a Johnson & Johnson company, has
acquired Amic, a privately held Swedish developer of in vitro
diagnostic technologies for use in point-of-care and
near-patient settings. 19 June 2008
Multidetector CT scan can
detect dissolved drugs
The smuggling of dissolved drugs, especially cocaine, in bottled
liquids can be decreased with the use of multidetector CT
according to a recent study conducted at Bern University. 3 June
2008
Quest Diagnostics
collaborates with Google to provide diagnostic test results
online
Doctors can securely provide diagnostic data with a brief
explanation of test results to a patient's Google Health
account. The system is expected to empower patients and
physicians to collaborate more closely in making more
well-informed healthcare decisions. 3 June 2008
Siemens and LabCorp to
co-develop clinical diagnostic tests
Siemens Healthcare and Laboratory Corporation of America
Holdings (LabCorp) have announced that they are exploring
possibilities to co-develop new clinical diagnostic tests in the
areas of companion diagnostics, metabolic syndrome, oncology and
diabetes. 12 May
Cranfield University tries new
approach to TB diagnosis with breath test
A project to develop new technology for TB diagnosis will search
for markers given off in volatile gases, such as breath, and
program the data into existing portable devices, such as
artificial noses, to provide a new screening method for the
rapidly spreading disease. 29 April 2008
 First
3-D image of antibody gene
Scientists at the University of California, San Diego have shown
for the first time how a genome is organized in
three-dimensional space. They used a multidisciplinary mix of
geometry, biological research and techniques developed to solve
problems on supercomputers. 29 April 2008
Valdemar Hospital establishes
point-of-care testing system
The Valdemar Private Hospital in Ringsted, Denmark, has invested
in a point-of-care testing (POCT) service from Capio
Diagnostics. The service includes remote monitoring and
management of the POCT testing at the hospital from Capio
Diagnostics’ monitoring centre in the UK. 17 April 2008
Dutch molecular medicine
institute allocates €150m
for disease research
The Center for Translational Molecular Medicine (CTMM) in
Eindhoven has awarded €150
million of funding for nine research projects directed at the
most prevalent diseases in the cardiovascular area, cancer and
neurodegeneration. 7 April 2008
 Smart clothing with
fluid biosensors to monitor health
The European BIOTEX project has produced textiles with woven-in
miniaturised biosensors that can analyse body fluids such as sweat to
assess the wearer's state of health. 31 March 2008
New breast cancer test uses magnetic
nanoparticles to detect cancer cells
A team from University College London has developed a new medical device
called the ‘HistoMag’ that will make the early detection of breast cancer
more accurate, cost effective and easier to administer. 10 March 2008
Chest to distribute Aerocrine airway
inflammation detector in Japan
Swedish airway products company Aerocrine AB has entered into a distribution
agreement with Chest MI Inc to market and sell Aerocrine's Niox Mino in
Japan. 20 February 2008
DNA test for assessing risk of prostate
cancer
deCODE genetics has launched a test that can identify genetic markers
associated with increased risk of prostate cancer. The company believes the
test will better predict the risk of prostate cancer and help to optimize
both screening and treatment. 20 February 2008
Acrongenomics targets Molecular Vision's
microfluidics point-of-care diagnostics devices
Swiss technology investment group Acrongenomics, Inc. has announced an
agreement with with Molecular Vision and The Imperial Venture Fund to
acquire Molecular Vision by the end of the first quarter this year. 15
February 2008
 Smart
holograms help self-diagnosis for patients
Patients with chronic diseases such as diabetes, cardiac problems, kidney
disorders or high blood pressure could benefit from the development of
sensors made from a new type of hologram. 4 February 2008
Roche increases diagnostics capability
with acquisition of Ventana
Pharmaceutical and diagnostics company Roche has bought US diagnostics
company Ventana Medical Systems for about $3.4 billion. 30 January
Summit on revolution in personalised
medicine caused by molecular diagnostics advances
Recent advances in genetic knowledge are transforming molecular imaging,
molecular diagnostics and informatics to create stunningly precise
diagnostic tools capable of assessing and treating a growing number of
critical diseases. The first international Molecular Summit on 5-6 February
will address this revolution in medicine. 30 January
Sysmex and bioMérieux form joint venture
for Japanese diagnostics market
Sysmex Corporation will take a 34% equity stake in bioMérieux Japan Ltd,
which will change its name to Sysmex bioMérieux Co Ltd. The new company will
market bioMérieux in-vitro diagnostics products Japan. 30 January 2008
Quidel and bioMérieux form alliance in
rapid diagnostics
Quidel Corporation and bioMérieux have formed an alliance to market products
worldwide and co-develop new rapid diagnostic tests using Quidel’s rapid
test development capability and bioMérieux’s extensive library of antibodies
and antigens. 16 January
Cepheid launches GeneXpert molecular
diagnostic system
Cepheid has begun shipment of its next generation GeneXpert self-contained
automated molecular analysis system. It automates and integrates DNA testing
and can test 60 targets in a single cartridge. 16 January
Siemens introduces MicroScan WalkAway plus
automated diagnostic systems
Siemens Medical Solutions Diagnostics has introduced the MicroScan WalkAway
plus Systems for mid- and high-volume clinical diagnostic microbiology
laboratories. They offer simultaneous automation of overnight, rapid and
specialty panels that test for both gram negative and gram positive
bacteria. 16 January
BD gains EU and US approval for rapid MRSA
test
BD Diagnostics has gained European approval for its BD GeneOhm StaphSR assay
for MRSA and SA in nasal and wound specimens and US FDA clearance to use the
test on positive blood cultures. The test can give results in two hours. 16
January
Glowing molecule detects prion diseases
An international team of researchers has developed a method of identifying
prion and other defective-protein diseases using a fluorescent molecule that
changes colour according to the disease present. 4 December 2007
 Breakthrough
in high sensitivity tuberculosis and malaria diagnosis
A new diagnostic system for detecting TB and malaria and suitable for use in
developing countries and remote areas has been developed by German company
Partec. The system combines Partec's battery-operated and mobile
fluorescence microscope with dedicated test kits developed by Merck. 4
December 2007
Quest Diagnostics' blood and herpes
point-of-care tests receive FDA clearance
Quest Diagnostics Incorporated (NYSE:DGX) has announced that its HemoCue and
Focus Diagnostics subsidiaries have received FDA 510(k) clearance for two
new point-of-care test kits that could speed up the time for diagnosis and
allow doctors to make immediate decisions about treatment. 21 November 2007
 New
sensor detects bird flu in minutes
A new biosensor developed at the Georgia Tech Research Institute can
detect bird flu in just minutes. The biosensor is economical,
field-deployable, sensitive to different viral strains and requires no
labels or reagents. 17 October 2007 New
laser method helps detect hidden liquid explosives and disease
A new and powerful technique that can detect hidden liquid explosives
through common plastic containers and glass bottles has been demonstrated by
scientists from the UK's Rutherford Appleton Laboratory. 8 October.
 Cometary
spectrometer targets tuberculosis
A miniature
mass spectrometer system, designed for the analysis of samples of a comet on
the European Space Agency Rosetta mission is being adapted into a
cost-effective, rapid and accurate tool for diagnosing tuberculosis (TB).
8 October
Gene sequencing identifies virus as
possible cause of honeybee catastrophe
Researchers at Columbia University, in collaboration with 454 Life Sciences,
a Roche company, have identified a virus implicated in the deaths of
millions of honeybee colonies using the company's genome sequencer system. 1
October 2007 Molecular vision in
collaboration to produce diagnostic device
Geneva. Molecular Vision Ltd, an offshoot from Imperial College, London, has
teamed up with Acrongenomics Inc and design company Pearson Matthews Ltd to
develop a point-of-care medical diagnostic device for detecting kidney and
cardiac biomarkers. 4 July 2007
Cellestis launches online service for new
blood test for TB
Australian medical diagnostics company Cellestis has created a website to
provide worldwide information on the availability of its QFT test for TB. 3
July 2007
 Non-invasive
diabetes detector unveiled
VeraLight Inc. has introduced an experimental device that uses light-induced
fluorescence to detect diabetes-related biomarkers found in skin. 2 July
2007
 Bacteria
place nanoparticles in cells to aid diagnosis or treatment
The natural infection mechanism of bacteria can be used to deliver
nanoparticles carrying drugs, DNA or sensors into cells for precise
diagnosis or treatment of disease. 19 June 2007
DiaGenic developing blood test for
Alzheimer’s disease
Using peripheral blood as an easy-to-collect sample, the test detects a
'gene signature' of the disease. 11 June 2007
Inverness Medical Innovations and Procter
& Gamble set up consumer diagnostics company
Inverness Medical Innovations, Inc. and The Procter & Gamble Company have
completed their previously announced deal to form a joint venture for
consumer diagnostic products, SPD Swiss Precision Diagnostics GmbH. 30 May
2007
Concentrating viral particles in electric
field could lead to rapid virus detector
Engineers in the US have solved a critical bottleneck in the transport and
capture of virus nanoparticles, making possible a device that could rapidly
sample and detect infectious biological agents, such as viruses. 9 May 2007
Sensor identifies trace samples of cells
and proteins in minutes
The sensor, which contains a millimeter-size cantilever, could have wide
applications in medical diagnostic testing, detecting contamination in food
products and monitoring for biothreat agents.
3M Health Care launches diagnostics unit
for rapid detection of infection
3M Health Care has created a new Medical Diagnostics business unit to
develop and commercialize rapid diagnostic products for detecting key
infectious pathogens such as MRSA and other treatment-resistant microbes. 28
March 2007
 Platinum-coated
nanotube biosensor detects glucose in near real time
Researchers at the University of Arkansas have fabricated a novel biosensor
that detects glucose in close to real time and with much greater sensitivity
than other comparable, biocompatible sensors. 21 March 2007
BioLED lab-on-chip technology to be
demonstrated at Imperial College, London
A demonstration version of the BioLED Lab On A Chip platform combining
microfluidics, organic semiconductor diodes and photodetectors will be
presented to a selected audience. 21 February 2007
3M takes over UK rapid diagnostics company
Acolyte Biomedica
The addition of Acolyte Biomedica allows 3M to expand more quickly into the
emerging market of infection prevention diagnostics, especially in Europe
where Acolyte Biomedica has a commercialized product for MRSA detection. 20
February 2007
Global molecular diagnostics market could
reach $92bn by 2016
The market will be driven by the addition of new tests in high-volume
testing areas coupled with the introduction of new instrumentation which
will provide greater ease, speed, and quality. 15 February 2007.
Rapid flu testing decreases antibiotic use
Rapid influenza testing is associated with reductions in the use of
antibiotics in hospitalized adults, according to a study published on
Archives of Internal Medicine online. 31 Jan 2007
US college wins grant to develop portable
device to detect bird flu and bioterrorism agents
The Medical College of Wisconsin in Milwaukee has been awarded a five-year,
$8.1 million grant from the National Institutes of Health’s Institute of
Allergy and Infectious Diseases (NIAID) to develop a rapid, miniaturized,
automated diagnostic device to test for avian flu and the majority of
potential bioterrorism agents. 23 January 2007
Roche Diagnostics launches cobas e 411
immunoassay analyzer
Roche Diagnostics has released its next generation bench-top immunoassay
analyzer, the cobas e 411 aimed at the low- to mid- volume immunoassay
market. 15 Jan 2007
Point-of-care diagnostics market to
surpass $16bn worldwide by 2010.
The demand for reduced costs and decentralized diagnostic testing in the US
is driving the market, according to research from Kalorama Information. 18
December 2006
Cepheid wins $14.9m contract from US CDC
for rapid detector of bird flu virus
Cepheid will develop a fully automated, self-contained test that will detect
the common forms of flu virus (influenza A/B) as well as H5N1 in about 30
minutes. 15 Dec 2006
Siemens' take over of Bayer Diagnostics
gains European approval
The €4.2 billion deal will allow Siemens' to combine its entire imaging
diagnostics, laboratory diagnostics and clinical information technology
value chain under one roof and create what the company claims is the world's
first full service diagnostics company. 3 Nov 2006
Akubio wins £800,000 grant to develop
electronic hand-held disease detectors
UK nanotechnology firm Akubio, has received a £826,000 government grant to
help develop its electronic technology for the rapid detection of viruses
and bacteria such as avian flu, E coli, malaria and meningitis. 24 Oct 2006
Electronic sensor to detect E coli
A sensor that can detect E coli bacteria within minutes by measuring changes
in frequency of vibration of the detector is being developed at Drexel
University in the USA. 24 Oct 2006
BD Biosciences releases flow cytometry
system for in vitro diagnostics use. 27 Sept 2006
 Disposable
glass microchip for large-scale screening of diseases
Researchers in Virginia have developed a disposable microchip that replaces
space-consuming instrumentation with fast, cost-effective, lab-on-a-chip
technology. The microfluidic device is suitable for large-scale screening of
disease-related biomarkers. 20 Sept 2006
 Silicon
'nanocantilevers' form ultrasensitive biological detectors
The tiny vibrating silicon structures created by researchers at Purdue
University vibrate at different frequencies when contaminants stick to them,
revealing the presence of dangerous substances. 12 Sept 2006
Bayer Diagnostics launches immunoassay
system. 8 Sept 2006
Paris University to study medical
applications of NanoArrayer
The Université Pierre & Marie Curie (UPMC) in
Paris is evaluating the BioForce Nanosciences NanoArrayer system. The
University will use the NanoArrayer to pattern proteins associated with cell
morphology establishment and migration. 24 August 2006
US approval for Abbott's fully automated
blood screening tests for hepatitis
Abbott has received approval from the US FDA for its Prism hepatitis B
surface antigen (HBsAg) and its Prism HBsAg confirmatory test. These tests
can be used to screen donated blood for HBsAg. 26 July 2006
 Liver
cells in silicon crystals screen drugs for toxicity
Researchers at the University of California, San Diego have developed a
'smart petri dish' that could be used to rapidly screen new drugs for toxic
interactions or identify cells in the early stages of cancer circulating
through a patient’s blood. 20 June 2006
Avian flu virus detector on a chip
BioWarn has demonstrated the capability to instantaneously detect avian
influenza virus (H5N1), also known as bird flu, using its new SmartSense
system. This combines biochemistry with silicon chip technology to make a
molecular identikit system for pathogens and other materials. 12 June 2006
Nikon launches ultra sensitive camera
for molecular fluorescence imaging
Nikon Instruments has introduced the Nikon EMCCD Monochrome Digital Camera (DQC-FS),
an ultra high-quality camera specifically designed for low-level
fluorescence such as single molecule fluorescence, high speed calcium
imaging and live cell fluorescent protein imaging. 7 June 2006
Varian develops new probes for nuclear
magnetic resonance of solid materials
Varian has launched the FastMAS and UltraFastMAS probes for analysing solid
materials and the BioStatic probe for determining the molecular structures
of proteins and other biomolecules in a solid state. 6 May 2006
Bruker Daltonics obtains Russian
medical device registration for mass spectrometers
Bruker Daltonics has obtained registration of its complete MALDI-TOF product
line of mass spectrometers, and its ClinProRobot sample preparation
platform. This will allow the Institute of Physico-Chemical Medicine in
Moscow to develop a novel system for the identification and characterization
of clinically relevant microorganisms. 1 May 2006
Mass spectrometry used to detect
norovirus pathogen in clinical samples
Researchers at Johns Hopkins University have demonstrated that proteomic
mass spectrometry has the potential to be used to identify viruses in
complex environmental samples. It has potential for use in biodefense and
public health preparedness. 25 April 2006
Rapid avian flu detection kits
Applied Biosystems has released its TaqMan Influenza A/H5 Detection Kit
for sale in in Europe, Asia, and Africa. It is capable of rapidly and
reliably detecting multiple strains of avian influenza in laboratory
samples. 14 March 2006
Molecular imager for in-vitro imaging
of protein biomarkers in tissue sections and cell clusters
Bruker Daltonics has launched the MALDI Molecular Imager for
high-sensitivity imaging of the spatial distribution of protein biomarkers
in biological, pathology and other clinical research. 14 March 2006
Hybrid sensor technology to
revolutionize high-end spectroscopy
Princeton Instruments/ Acton has developedva hybrid sensor technology that
combines the key benefits of both CCDS and CMOS sensors to yield a dedicated
spectroscopy detector, that has unparalleled sensitivity and speed. 13 March
2006
Definiens launches automated image
analyser for cell-based assays
Definiens has released Cellenger, a set of workflow tools and modular
components for cellular image analysis based on cognition software developed
for remote sensing. 10 February 2006
Molecular diagnostics market shows fast
growth
Based on its exceptional ability to accurately detect the primary cause of
disease, molecular diagnostics has emerged as the fastest growing segment of
the in vitro diagnostics (IVD) industry. 11 January 2006
Nano-scale medical devices could be
wired with unravelled DNA strands
Ohio State University researchers have uncoiled DNA strands and formed them
into precise patterns. They could act as wires in biologically based nano-scale
electronic and medical devices. 18 December 2005
University of Leeds pathology unit
expands tissue scanning capacity
The University of Leeds Academic Unit of Pathology has increased its
capacity to scan slides of tissue samples by acquiring five Aperio ScanScope
virtual microscopy systems. These will support a broad array of initiatives,
including potentially enabling primary diagnoses to be made without
referring to the glass slide. 7 September 2005
Siemens takes over development of 'lab
on a chip'
Siemens is taking over the development of an award-winning electrochemical
biochip from its partners in the project. The transfer to Siemens involves
patents, a high-tech biochip lab as well as experts with the know-how of
silicon biochip manufacture. 23 June 2005
To top |